base
avail
metabolom
studi
influenza
infect
affect
varieti
cellular
metabol
pathway
ensur
optim
environ
replic
product
viral
particl
follow
infect
glucos
uptak
aerob
glycolysi
increas
infect
cell
continu
result
higher
glucos
consumpt
pentos
phosphat
shunt
anoth
glucoseconsum
pathway
enhanc
influenza
infect
help
produc
nucleotid
especi
atp
regard
lipid
speci
follow
infect
level
triglycerid
phospholipid
sever
lipid
deriv
undergo
perturb
associ
inflammatori
respons
also
mitochondri
fatti
acid
decreas
significantli
simultan
increas
biosynthesi
fatti
acid
membran
lipid
moreov
essenti
amino
acid
demonstr
declin
infect
tissu
due
product
larg
amount
viral
cellular
protein
immun
respons
influenza
infect
hand
could
significantli
affect
metabol
pathway
mainli
interferon
ifn
product
follow
viral
infect
affect
cell
function
via
alter
amino
acid
synthesi
membran
composit
lipid
metabol
understand
metabol
alter
requir
influenza
viru
replic
reveal
novel
therapeut
method
base
target
inhibit
cellular
metabol
pathway
influenza
viru
infect
ivi
one
common
infecti
agent
capabl
infect
varieti
avian
mammalian
speci
viru
respons
season
epidem
lead
million
sever
infect
death
annual
despit
annual
vaccin
program
high
mortal
rate
caus
influenza
infect
variou
complic
includ
chronic
lung
diseas
cardiac
diseas
asthma
metabol
disord
yet
adequ
address
eagl
et
al
first
indic
addit
glucos
hela
cell
medium
could
promot
gener
polioviru
progeni
result
publish
studi
show
replic
influenza
viru
depend
host
cellular
metabol
metabolit
includ
nucleic
acid
protein
glycoprotein
lipid
crucial
requir
life
cycl
influenza
viru
recent
research
mous
model
show
influenza
infect
could
affect
metabolit
marker
serum
lung
bronchoalveolar
lavag
fluid
acquir
requir
materi
host
cell
selfrepl
viru
disrupt
biochem
process
glycolysi
fatti
acid
fa
synthesi
glutamin
pathway
particular
import
scientist
broaden
horizon
metabol
chang
influenza
infect
turn
pave
way
prevent
lifethreaten
consequ
influenza
infect
activ
provok
prooxid
condit
host
cell
facilit
viral
prolifer
pathogenesi
increas
express
influenza
protein
activ
protein
kinas
c
increas
reactiv
oxygen
speci
ro
product
hand
decreas
superoxid
anion
dismutas
express
consequ
disrupt
ro
scaveng
process
peopl
influenza
infect
increas
level
dna
lipid
protein
oxid
product
found
plasma
urin
also
increas
level
ro
induc
nitric
oxid
synthas
ino
observ
marker
oxid
stress
lung
peopl
die
due
pandem
influenza
infect
rosproduc
enzym
induc
influenza
infect
mainli
includ
nadph
oxidas
nox
xanthin
oxidas
upregul
caus
impair
defens
function
antioxid
increas
ro
product
along
impair
antioxid
function
ultim
lead
profound
chang
redox
homeostasi
cell
phagocyt
enzym
involv
product
ro
induc
influenza
viru
impair
express
result
lack
increas
rn
ro
product
follow
influenza
infect
xanthin
oxidas
also
rosproduc
enzym
induc
influenza
infect
inhibit
hinder
ro
increas
cell
hand
increas
express
reduc
influenza
viru
titer
within
cell
also
report
influenza
infect
significantli
increas
ro
product
induc
prolifer
viru
lung
epitheli
cell
depend
redoxsensit
pathway
activ
ro
glutathion
gsh
vital
antioxid
cell
cellular
content
invers
relat
influenza
viru
replic
cell
indic
higher
level
gsh
antioxid
enzym
glutathion
peroxidas
antiapoptot
protein
lung
femal
mice
result
superior
resist
mice
influenza
infect
contrast
male
mice
suscept
infect
due
higher
express
differ
due
primarili
higher
abil
femal
mice
maintain
cellular
redox
homeostasi
amator
et
al
also
show
increas
gsh
content
organ
affect
gshdepend
antivir
pathway
strengthen
immun
system
particular
cell
respons
decreas
viral
replic
howev
gsh
deplet
result
deviat
respons
toward
cell
furthermor
oxid
stress
follow
infect
induc
transcript
factor
nfkb
subsequ
lead
increas
level
inflammatori
cytokin
includ
interleukin
il
ifn
tnf
ifn
one
cytokin
trigger
affect
cell
metabol
via
mediat
glucos
uptak
glycolysi
lipid
synthesi
ifn
also
exert
function
metabol
chang
produc
sever
mediat
includ
ido
nitric
oxid
appear
either
induc
inhibitori
role
viral
replic
sinc
tryptophan
critic
cell
prolifer
deplet
amino
acid
ido
suppress
immun
system
stimul
regulatori
cell
hand
inhibit
viral
replic
via
chang
structur
viral
protein
review
first
discuss
metabol
abnorm
influenza
infect
shed
light
role
immunometabolit
regul
cellular
metabol
follow
section
summar
recent
evid
novel
therapeut
approach
target
metabol
pathway
influenza
infect
virus
take
advantag
variou
cellular
mechan
replic
effici
vital
metabol
pathway
host
cell
one
wide
use
mechan
target
virus
result
consider
chang
context
studi
reveal
variou
human
virus
cytomegaloviru
rubella
dengu
mump
polioviru
reoviru
strongli
affect
host
cell
glycolysi
lipid
metabol
glutaminolysi
furthermor
review
sanchez
lagunoff
delin
activ
metabol
process
sever
virus
discuss
section
influenza
highli
pathogen
human
viru
interfer
tremend
host
metabol
cycl
therebi
forc
produc
viral
particl
effici
metabol
concentr
glucos
cell
play
cardin
role
homeostasi
cellular
metabol
procedur
shortli
onset
ivi
rate
glucos
uptak
infect
cell
increas
continu
subsequ
enhanc
glycolysi
result
higher
glucos
consumpt
product
viral
particl
extracellular
concentr
lactat
relationship
glycolysi
ivi
shown
influenza
infect
higher
multipl
infect
moi
rais
glycolyt
activ
cell
studi
kohio
adamson
dosespecif
increas
influenza
infect
associ
higher
glucos
level
wherea
treatment
cell
glycolysi
inhibitor
remark
suppress
viral
replic
howev
viral
infect
could
retrigg
ad
atp
cell
environ
studi
reveal
enhanc
vacuolartyp
atpas
proton
pump
essenti
influenza
uncoat
via
increas
glucos
metabol
result
higher
avail
atp
resourc
augment
viru
infect
observ
mention
reveal
signific
increas
atp
glucos
consumpt
within
cell
follow
influenza
infect
also
highlight
depend
influenza
viru
glycolysi
pathway
energi
product
viral
replic
highest
use
atp
influenza
infect
releas
larg
quantiti
energi
form
heat
process
increas
temperatur
infect
cell
viral
prolifer
increas
cellular
atp
level
drop
sharpli
result
reduc
potenti
stabil
mitochondri
membran
base
avail
result
patient
metabol
disord
develop
sever
influenza
infect
compar
healthi
host
sever
studi
show
diabet
increas
risk
influenza
infect
sever
diseas
fatal
consequ
infect
patient
type
diabet
overweight
obes
signific
risk
factor
sever
influenza
infect
reinforc
effect
diabet
influenza
may
due
inhibitori
effect
hyperglycemia
immun
system
shown
hyperglycemiaassoci
immunosuppress
suscept
influenza
infect
allevi
insulin
administr
diabet
control
hand
pentos
phosphat
pathway
ppp
anoth
glucoseconsum
pathway
report
enhanc
ivi
contribut
higher
yield
nucleotid
atp
viral
replic
signific
upregul
ppp
key
enzym
influenzainfect
cell
includ
glucos
dehydrogenas
dehydrogenas
report
jank
et
al
enzym
also
respons
gener
nadph
critic
compon
fatti
acid
biosynthesi
level
activ
specifi
abil
cell
clear
accumul
ro
cell
averag
level
retain
appropri
gshgssg
ratio
keep
ro
product
toler
low
level
indic
activ
invers
correl
cellular
ro
level
disrupt
redox
balanc
shown
contribut
replic
virul
sever
virus
defici
caus
disrupt
despit
result
report
jank
et
al
activ
seem
invers
relat
respiratori
viral
infect
exampl
vitro
studi
infect
human
coronaviru
hcov
product
viral
particl
cell
higher
healthi
cell
correl
increas
oxid
product
molecular
mechan
viru
control
metabol
pathway
thoroughli
identifi
smallwood
et
al
shown
increas
glucos
uptak
glycolysi
glutaminolysi
follow
influenza
infect
may
relat
loss
pathway
homeostasi
subsequ
increas
cmyc
express
infect
cell
regard
avail
result
mechanist
target
rapamycin
complex
signal
activ
varieti
influenza
viru
protein
viral
hemagglutinin
ha
protein
along
viru
replic
upregul
phosphoryl
activ
akt
requir
induct
signal
pathway
influenza
viru
hand
influenza
protein
capabl
downregul
inhibitor
therebi
enhanc
activ
signal
turn
promot
cmyc
express
translat
level
addit
protein
effect
promot
activ
turn
upregul
cmyc
foxo
inhibit
moreov
aktdepend
inactiv
foxo
increas
glycolysi
remov
suppress
forc
cmyc
myc
enhanc
glycolysi
upregul
express
glucos
transport
glycolyt
gene
lactat
dehydrogenas
ldh
convert
pyruv
lactat
also
mediat
upregul
hypoxiainduc
factor
increas
express
variou
gene
includ
sever
glycolyt
enzym
glucos
transport
ldh
akt
abl
promot
express
membran
local
well
function
phosphofructokinas
furthermor
akt
demonstr
activ
srebp
manner
upregul
srebp
enhanc
stabil
process
form
shown
requir
increas
express
ratelimit
enzym
ppp
oxid
branch
addit
abovement
metabol
pathway
influenza
viru
exhibit
disrupt
effect
metabol
process
give
rise
metabol
disord
atp
crisi
previou
studi
found
influenza
infect
increas
cellular
synthesi
fatti
acid
deriv
includ
eicosanoid
molecul
natur
endogen
ligand
stimul
peroxisom
proliferationactiv
receptor
ppar
ppar
group
nuclear
receptor
protein
act
transcript
factor
regul
express
differ
gene
involv
cellular
differenti
metabol
carbohydr
lipid
protein
furthermor
type
ppar
discov
far
abl
suppress
activ
pyruv
dehydrogenas
pdh
enzym
known
catalyz
oxid
decarboxyl
pyruv
lead
acetylcoa
product
variou
organ
upregul
pyruv
dehydrogenas
kinas
pdk
respect
extrem
low
pdh
enzym
activ
found
influenza
infect
vitro
enhanc
inhibit
pdh
found
lung
tissu
influenzainfect
mice
enzym
inhibit
contribut
erron
process
caus
signific
disrupt
glucos
oxid
cellular
respir
lipid
metabol
fig
follow
infect
level
phospholipid
sever
lipid
deriv
undergo
perturb
sever
line
evid
shown
obes
mice
due
abnorm
fig
metabol
chang
caus
influenza
infect
relat
mechan
sever
anabol
catabol
process
affect
higher
glucos
uptak
metabol
glycolysi
pentos
phosphat
pathway
higher
nucleotid
catabol
increas
biosynthesi
fatti
acid
includ
arachidon
acid
precursor
proinflammatori
lipid
also
enhanc
glutaminolysi
protein
synthesi
activ
signal
downstream
factor
influenza
infect
may
essenti
role
upregul
metabol
process
addit
high
atp
consumpt
reduc
well
glucos
oxid
influenza
infect
contribut
atp
crisi
henc
influenzarel
multiorgan
failur
influenzamedi
elev
aa
consist
inflamm
also
report
studi
accumul
abovement
proinflammatori
lipid
cell
lead
promot
synthesi
eicosanoid
inflammatori
mediat
thu
exacerb
postinfect
necrosi
inflamm
tissu
damag
lung
prospect
cohort
studi
influenzainfect
subject
lipid
inflammatori
mediat
serum
sampl
patient
mainli
aaderiv
oxylipin
includ
although
metabolit
shown
elev
shortli
infect
level
remain
consider
high
week
postinfect
indic
constant
pulmonari
inflamm
pulmonari
surfact
system
involv
suppress
influenza
infect
respiratori
tract
disrupt
due
signific
influenzainduc
chang
abund
differ
type
pc
pe
speci
major
compon
surfact
tanner
et
al
propos
princip
correl
influenza
replic
cholin
lipid
metabol
found
ivimedi
reduct
esterlink
pc
speci
well
increas
level
sphingomyelin
sm
probabl
connect
expend
cellular
cholin
store
sm
synthesi
led
increas
sm
speci
within
infect
cell
sm
shortchain
fatti
acidcontain
etherlink
pc
epc
speci
found
higher
amount
infect
cell
virion
therefor
appear
involv
viral
morphogenesi
hand
longchain
fatti
acidcontain
epc
increas
infect
cell
low
level
structur
virion
highlight
role
phospholipid
replic
viru
evid
higher
product
complex
lipid
cell
requir
increas
biosynthesi
fatti
acid
regard
result
studi
reveal
influenza
infect
could
induc
fatti
acid
biosynthesi
cholesterol
metabol
human
lung
basal
epitheli
tumor
cell
sinc
srebp
thoroughli
identifi
stimul
express
mani
gene
involv
lipid
sterol
biosynthesi
includ
fatti
acid
synthas
upregul
influenza
viru
induct
signal
discuss
earlier
may
logic
explain
increas
rate
lipogenesi
coincid
increas
fatti
acid
synthesi
declin
fatti
acid
found
influenza
infect
attribut
varieti
mechan
directli
indirectli
relat
viral
replic
instanc
sharp
increas
proinflammatori
cytokin
influenza
infect
caus
decreas
hepat
fatti
acid
vitro
vivo
like
excess
nitric
oxid
relat
free
radic
addit
increas
temperatur
cell
infect
could
result
viru
replic
fever
caus
heat
stress
turn
consider
downregul
carnitin
palmitoyltransferas
ii
cpt
ii
activ
reduc
atp
level
fibroblast
influenzaassoci
encephalopathi
patient
healthi
volunt
studi
influenzainfect
mice
demonstr
signific
depress
long
hepat
chain
fatti
acid
mrna
protein
level
sever
essenti
enzym
reduc
signific
decreas
mitochondri
fatti
acid
simultan
increas
biosynthesi
fatti
acid
membran
lipid
may
reflect
fact
viru
store
structur
lipid
produc
infecti
particl
addit
impair
metabol
mitochondria
influenza
infect
induc
sever
peroxisom
lipid
metabol
disord
infer
abnorm
level
sever
specif
longchain
fatti
acid
fig
aforement
metabol
process
pathway
affect
influenza
viru
infect
viru
abil
induc
higher
consumpt
rate
glutamin
glutaminolysi
attribut
transient
cmyc
overexpress
myc
act
regul
glutamin
uptak
util
cell
demonstr
catalyt
activ
glutaminas
key
enzym
glutaminolysi
greatli
increas
follow
infect
moreov
essenti
amino
acid
especi
tryptophan
materi
whose
quantiti
shown
declin
infect
tissu
upregul
protein
synthesi
sever
downstream
factor
thu
induct
signal
influenza
viru
lead
higher
usag
essenti
amino
acid
storag
concurr
product
larg
amount
viral
cellular
protein
infect
influenza
viru
also
alter
cellular
level
metabol
purin
pyrimidin
associ
increas
activ
nucleotid
catabol
core
enzym
includ
adenosin
deaminas
ada
xanthin
oxidas
xo
elev
level
inosin
hypoxanthin
xanthin
uric
acid
serum
bronchoalveolar
lavag
fluid
enhanc
catabol
degrad
nucleotid
metabolit
facilit
product
superoxid
contribut
pathogenesi
influenza
infect
interferon
wellknown
cytokin
power
capabl
alter
cellular
function
follow
viral
infect
alter
affect
protein
synthesi
composit
membran
cellular
prolifer
nutrit
statu
interferon
stimul
gene
isg
effector
compon
whose
transcript
could
induc
type
ifn
studi
recent
underscor
gener
effect
ifn
energi
metabol
cell
mostli
promot
glycolysi
instanc
shown
induc
glucos
uptak
embryon
fibroblast
manner
therebi
increas
atp
product
also
demonstr
type
ifn
stimul
oxygen
consumpt
rang
cell
includ
convent
dendrit
cell
dc
keratinocyt
memori
cell
inde
high
yield
atp
mitochondri
fit
guarante
host
cell
need
energi
plasmacytoid
dc
pdc
nonhematopoiet
cell
follow
challeng
viral
pathogen
studi
emphas
mediatori
effect
type
ifn
glycolysi
induct
via
also
shown
influenza
infect
stimul
pdc
enhanc
glycolysi
develop
warburglik
remodel
energi
metabol
enhanc
glycolysi
lead
higher
ifn
product
consequ
potent
antivir
activ
induc
metabol
reprogram
macrophag
rapid
increas
aerob
glycolysi
follow
reduct
oxid
phosphoryl
metabol
reprogram
maintain
cell
viabil
inflammatori
respons
reduc
depend
mitochondri
oxid
metabol
excess
product
proinflammatori
cytokin
chemokin
human
monocytesmacrophag
block
inhibit
aerob
glycolysi
also
activ
macrophag
induc
express
atpcitr
lyas
enzym
acli
blockag
acli
activ
reduc
product
ro
nitric
oxid
strong
consensu
influenza
replic
crucial
depend
fatti
acid
make
fascin
target
therapeut
modal
thu
abil
ifn
channel
fa
biosynthesi
catabol
via
fatti
acid
oxid
fao
current
known
promis
antivir
strategi
pdc
requir
research
elucid
sever
line
current
evid
reveal
antivir
activ
type
ifn
exert
hamper
glucosederiv
cholesterol
fatti
acid
synthesi
sterol
regulatori
bind
protein
along
known
lead
transcript
factor
orchestr
biosynthesi
pathway
sterol
whose
inhibit
transcript
express
strongli
mediat
ifn
via
fig
recognit
lead
induct
inflammatori
respons
turn
control
replic
spread
viru
correl
increas
transcript
cytokin
respons
mice
sever
infect
viru
lead
upregul
inflammatori
cytokin
gene
along
downregul
lipid
metabol
coagul
gene
uncontrol
proinflammatori
respons
accompani
inadequ
antiinflammatori
respons
refer
cytokin
storm
monocytesmacrophag
neutrophil
lung
epitheli
cell
use
role
cytokin
storm
develop
influenza
infect
sever
cytokin
storm
greater
level
interferon
tumor
necrosi
factor
recogn
patient
hospit
due
influenza
infect
influenzainduc
cytokin
storm
togeth
viral
virul
develop
sever
lung
injuri
patient
believ
level
cytokin
storm
directli
associ
sever
diseas
caus
influenza
infect
specif
polymorph
immun
system
gene
determin
role
outcom
influenza
infect
previou
studi
shown
relationship
cytokin
gene
polymorph
sever
influenza
diseas
sever
cytokin
evalu
influenza
viru
infect
among
gg
ag
gg
gt
genotyp
tt
polymorph
associ
increas
risk
influenza
infect
contrast
gg
gg
tg
genotyp
associ
reduc
risk
infect
anoth
studi
associ
genotyp
sever
influenza
diseas
found
polymorph
associ
influenza
diseas
also
lack
allel
could
increas
risk
influenza
infect
polymorph
immun
system
gene
may
associ
metabol
chang
turn
may
reinforc
metabol
disord
follow
influenza
infect
howev
addit
studi
need
field
confirm
reject
opinion
ifn
known
capabl
deplet
polyamin
limit
viru
replic
polyamin
small
ornithinederiv
polycation
molecul
encompass
three
molecul
putrescin
spermidin
spermin
spermidin
spermin
deplet
one
compel
mechan
ifn
produc
antivir
effect
replic
rna
virus
mechanist
speak
polyamin
appear
play
pivot
role
process
rna
transcript
protein
translat
virus
make
promis
target
combat
viral
infect
ltryptophan
one
nine
essenti
amino
acid
remark
role
immunosuppress
toler
also
essenti
protein
kynurenin
serotonin
synthesi
ido
intracellular
enzym
induc
product
kynurenin
ltryptophan
therebi
act
deplet
tryptophan
modul
immun
system
follow
viral
infect
two
ifnstimul
respons
element
three
site
promot
ido
act
power
induc
express
ido
also
shown
express
influenza
infect
dendrit
cell
macrophag
epitheli
cell
express
ido
sinc
primari
target
replic
influenza
primarili
found
respiratori
epitheli
cell
understand
role
ido
influenza
infect
particular
import
exist
coincid
peak
ifnk
express
influenza
infect
also
mous
lung
airway
consider
express
ifn
type
iii
follow
infect
influenza
find
emphas
upregul
express
enhanc
function
ido
influenza
infect
found
induc
ifni
moreov
ifni
thought
signal
adjac
cell
via
ifnir
stimul
produc
ido
nonetheless
ifnmedi
ido
induct
influenza
infect
gener
undesir
consequ
establish
immun
toler
inde
inhibitori
effect
tryptophan
deplet
cell
respons
confirm
also
ido
induc
kynurenin
deriv
tryptophan
lead
stimul
regulatori
cell
nowaday
ido
hypothes
part
metabol
immun
regul
play
protect
role
immun
respons
inhibit
overreact
respons
influenza
infect
pleiotrop
role
attribut
ido
infect
give
rise
oppos
outcom
fig
research
role
ido
influenza
infect
mainli
focus
murin
model
influenza
infect
emphas
increas
ido
activ
maximum
express
correl
increas
lymphocyt
number
respiratori
tract
nitric
oxid
gaseou
free
radic
access
vasodilatori
microbicid
function
howev
antivir
effect
also
document
lead
reduc
viral
load
effici
clearanc
infect
nitrosyl
viral
molecul
offer
antivir
mechan
employ
also
synthasemedi
gener
lead
deplet
larginin
therebi
reduc
level
polyamin
thu
ifninduc
repres
antivir
activ
turn
may
exhibit
anoth
mechan
ifn
hinder
viral
infect
influenza
despit
exist
data
regard
antivir
activ
mani
studi
consid
doubleedg
sword
pathogen
viricid
effect
role
pathogenesi
pneumonia
caus
influenza
viru
infect
describ
mice
respons
induc
greatli
increas
level
ino
lung
infect
mice
lead
product
signific
amount
peroxynitrit
speci
among
import
pathogen
factor
influenza
virusinduc
pneumonia
mice
uetani
et
al
also
observ
overexpress
ino
gene
human
airway
epitheli
cell
induc
influenza
viru
infect
addit
produc
phagocyt
cell
antivir
activ
simultan
nonspecif
damag
host
cell
viral
pathogenesi
survey
nin
et
al
pandem
influenza
infect
case
show
increas
level
ino
protein
tyrosin
nitrat
oxygen
free
radic
indic
product
peroxynitrit
result
reveal
involv
oxid
nitr
stress
pathogenesi
influenza
virusinduc
acut
respiratori
distress
syndrom
ard
influenzainduc
cytokin
stimul
releas
human
airway
epitheli
cell
mention
previous
influenza
infect
induc
upregul
interestingli
macrophag
show
decreas
express
ino
stimul
indic
possibl
involv
influenza
pathogenesi
shown
infect
virus
induc
higher
level
mice
compar
season
viru
result
develop
intens
pathogen
outcom
mice
ino
defici
show
reduc
morbid
mortal
cytokin
product
lung
follow
viru
infect
also
system
administr
no
inhibitor
could
postpon
weight
loss
death
among
virusinfect
mice
anoth
survey
deliveri
influenzainfect
mice
could
improv
lung
infect
surviv
mice
indic
administr
suitabl
treatment
strategi
influenza
although
probabl
due
difficulti
determin
concentr
viricid
safe
host
airway
also
report
releas
snitrosonacetylpenicillamin
snap
reduc
replic
influenza
viru
dosedepend
manner
product
airway
epitheli
cell
lead
antivir
rather
harm
effect
follow
influenza
infect
provid
product
precis
control
sinc
influenza
viru
affect
world
popul
annual
prevent
therapeut
approach
requir
much
closer
attent
therapeut
drug
influenza
infect
fall
three
group
neuraminidas
inhibitor
zanamivir
oseltamivir
laninamivir
peramivir
inhibitor
rimantadin
amantadin
polymeras
inhibitor
favipiravir
antivir
drug
resist
recent
emerg
global
problem
bring
remark
financi
social
burden
therefor
research
urgent
need
develop
novel
promis
antivir
drug
mani
metabol
pathway
influenza
infect
increasingli
chang
dampen
appear
hamper
viru
replic
one
newli
develop
strategi
aim
hinder
influenza
infect
target
metabol
pathway
restor
hemostasi
cell
tabl
signal
pathway
shown
play
pivot
role
varieti
cellular
pathway
includ
prolifer
nutrient
uptak
activ
increas
glucos
uptak
upregul
cell
surfac
glucos
transport
alter
glucos
metabol
via
blockag
pathway
clinic
trial
underway
assess
strategi
cancer
therapi
smith
et
al
hand
sever
line
evid
demonstr
sirna
target
pathway
therebi
ward
influenza
infect
new
studi
smallwood
et
al
found
although
interfer
earli
stage
infect
could
final
reduc
viral
progeni
result
prolong
surviv
mice
challeng
influenza
viru
inde
induc
hemostasi
pathway
via
phosphoryl
reconstitut
metabol
statu
alreadi
alter
viru
found
elev
level
lung
liver
heart
influenza
infect
level
atp
pdh
key
enzym
regul
glucos
lipid
atp
level
human
cell
shown
reduc
furthermor
dichloroacet
dca
pyruv
dehydrogenas
kinas
inhibitor
antitumor
activ
varieti
carcinoma
studi
also
indic
diisopropylamin
dichloroacet
dada
could
amelior
metabol
hepatocyt
chronic
liver
diseas
studi
yaman
et
al
attempt
evalu
effect
dada
influenzainfect
mice
oral
administr
dada
found
restor
activ
pdh
atp
affect
organ
also
suppress
cytokin
storm
viral
replic
sterol
intermedi
metabolit
play
essenti
role
broad
spectrum
biolog
pathway
includ
inflamm
research
shown
interferon
product
follow
immun
respons
viral
infect
regul
sterol
product
path
blanc
et
al
reveal
sterol
metabol
pathway
regul
simvastatin
zometa
zoledron
acid
fpt
inhibitor
iii
could
effect
hinder
influenza
replic
cytokin
product
make
promis
therapeut
candid
acut
patient
hand
mention
earlier
srebp
transcript
factor
critic
role
process
lipogenesi
studi
shown
factor
play
varieti
role
energi
suppli
posttransl
protein
modif
well
propag
variou
group
virus
influenza
virus
studi
shown
compound
retinoid
deriv
inhibit
srebplink
pathway
antivir
activ
influenza
coronaviru
vitro
vivo
concern
fact
mitochondria
glycolysi
two
sourc
energi
product
play
vital
role
regul
innat
immun
respons
immun
system
respons
especi
cytokin
storm
follow
influenza
infect
atp
synthesi
mitochondria
decreas
lead
weaken
innat
immun
respons
dengb
yao
studi
reveal
tradit
herbal
medicin
import
role
improv
influenzalik
symptom
infect
patient
result
studi
demonstr
pretreat
infect
cell
hochuekkito
tradit
japanes
herbal
medicin
could
activ
mitochondri
glycolyt
energi
metabol
therebi
intensifi
symptom
also
effect
tradit
chines
medicin
modifi
jiu
wei
qiang
huo
infect
mice
evalu
anoth
studi
result
show
herbal
medicin
could
amelior
weight
loss
inflammatori
mediat
infect
mice
regul
amino
acid
fatti
acid
arachidon
acid
pathway
base
recent
studi
influenza
viru
infect
interfer
cellular
metabol
pathway
either
directli
indirectli
via
stimul
immun
system
mediat
enhanc
activ
complex
influenza
viru
strengthen
sever
metabol
pathway
includ
glycolysi
glutaminolysi
pentos
phosphat
fatti
acid
synthesi
provid
atp
structur
materi
viral
replic
hand
suppress
follow
viral
infect
help
suppli
essenti
fatti
acid
synthesi
structur
lipid
howev
exhaust
cellular
atp
resourc
due
viru
replic
well
increas
proinflammatori
lipid
synthesi
ultim
lead
irrevers
cell
damag
innat
immun
respons
follow
influenza
infect
play
crucial
role
metabol
alter
ifn
one
mediat
act
sever
metabolit
ido
therebi
affect
lipid
amino
acid
pathway
sinc
drug
resist
influenza
infect
global
concern
research
design
novel
therapeut
modal
tackl
pandem
particular
import
thu
clear
understand
metabol
alter
influenza
infect
would
tremend
help
therapeut
purpos
